Animalcare has announced that a new indication for chronic renal insufficiency in cats has been approved in the licence for Benazecare 5mg.

Benazecare is a POM-V ACE (angiotensin converting enzyme) inhibitor containing benazepril hydrochloride, which was originally launched in the UK in 2007 for the treatment of congestive heart failure in dogs.

For more information, contact Animalcare at www.animalcare.co.uk

PS: Whilst you're here, take a moment to see our latest job opportunities for vets.